Brazil, the largest country in South America, has become the second largest pharmaceutical market in the emerging world. The Brazillian Health Surveillance Agency (Agencia Nacional de Vigilancia Sanitaria - ANVISA) was created in 1999 with the primary goal to protect and promote public health surveillance over products and services in Brazil. The governing body and structure of this new regulatory agency will be the aims of this paper, where the authors hope to share their understanding on the regulatory processes and its significant importance of this agency.

中文翻译：

---

ANVISA：面临许多挑战的新监管机构简介

巴西是南美最大的国家，已成为新兴国家的第二大制药市场。巴西卫生监督局（Agencia Nacional de Vigilancia Sanitaria-ANVISA）成立于1999年，其主要目标是保护和促进巴西产品和服务的公共卫生监督。这个新监管机构的管理机构和结构将是本文的目标，作者希望在此分享他们对监管程序及其对该机构的重要意义的理解。